We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.9%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.72B
AUM Growth
-$313M
(-6.2%)
Cap. Flow
-$247M
Cap. Flow
% of AUM
-5.24%
Top 10 Holdings %
Top 10 Hldgs %
13.35%
Holding
1,246
New
455
Increased
271
Reduced
328
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$32.6M |
| 2 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$31.7M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$28.2M |
| 4 |
Targa Resources
TRGP
|
+$25.3M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$50.8M |
| 2 |
Walt Disney
DIS
|
+$49.8M |
| 3 |
Accenture
ACN
|
+$41.1M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$35.4M |
| 5 |
Valero Energy
VLO
|
+$30.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 13.89% |
| 4 | Consumer Discretionary | 12.13% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NPTN
701
DELISTED
NEOPHOTONICS CORP
NPTN
| $573K | 0.01% |
+40,781
| New | +$422K |
|
702
BancFirst
BANF
$3.92B
| $571K | 0.01% |
20,032
+5,120
| +34% | +$144K |
|
|
BBRG
703
DELISTED
Bravo Brio Restaurant Group Inc.
BBRG
| $571K | 0.01% |
73,729
+500
| +0.7% | +$4.06K |
|
|
SEE
704
DELISTED
Sealed Air
SEE
| $570K | 0.01% |
11,880
-5,640
| -32% | -$247K |
|
705
Tanger
SKT
$4.82B
| $557K | 0.01% |
15,309
-89,620
| -85% | -$2.95M |
|
|
AHT
706
Ashford Hospitality Trust
AHT
$21M
| $555K | 0.01% |
88
+64
| +267% | +$347K |
|
707
Marchex
MCHX
$79.7M
| $550K | 0.01% |
123,701
-16,300
| -12% | -$65.5K |
|
|
CRR
708
DELISTED
Carbo Ceramics Inc.
CRR
| $548K | 0.01% |
+38,600
| New | +$666K |
|
709
Acuity Brands
AYI
$9.88B
| $537K | 0.01% |
2,460
+80
| +3% | +$16.5K |
|
|
PDCO
710
DELISTED
Patterson Companies, Inc.
PDCO
| $536K | 0.01% |
11,520
-37,320
| -76% | -$1.62M |
|
|
GIFI
711
DELISTED
Gulf Island Fabrication
GIFI
| $529K | 0.01% |
67,433
+24,537
| +57% | +$214K |
|
|
CTRL
712
DELISTED
Control4 Corporation
CTRL
| $524K | 0.01% |
+65,790
| New | +$489K |
|
713
Cytokinetics
CYTK
$11B
| $522K | 0.01% |
74,087
-9,400
| -11% | -$68.7K |
|
|
VOXX
714
DELISTED
VOXX International Corporation Class A
VOXX
| $522K | 0.01% |
116,699
+1,497
| +1% | +$6.54K |
|
715
Celldex Therapeutics
CLDX
$2.77B
| $521K | 0.01% |
+9,180
| New | +$1.03M |
|
716
Green Plains
GPRE
$1.19B
| $520K | 0.01% |
+32,600
| New | +$524K |
|
717
Norwegian Cruise Line
NCLH
$8.89B
| $520K | 0.01% |
9,404
-88,496
| -90% | -$4.26M |
|
|
BFX
718
DELISTED
BowFlex Inc.
BFX
| $520K | 0.01% |
26,900
-11,600
| -30% | -$218K |
|
|
RXDX
719
DELISTED
Ignyta, Inc.
RXDX
| $517K | 0.01% |
+76,348
| New | +$629K |
|
|
SKUL
720
DELISTED
SKULLCANDY INC
SKUL
| $515K | 0.01% |
144,530
+117,000
| +425% | +$421K |
|
721
Plexus
PLXS
$6.81B
| $514K | 0.01% |
13,000
-1,240
| -9% | -$43.9K |
|
|
CASC
722
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $513K | 0.01% |
67,272
+56,172
| +506% | +$433K |
|
|
ALOG
723
DELISTED
Analogic Corp
ALOG
| $506K | 0.01% |
+6,400
| New | +$479K |
|
|
CBR
724
DELISTED
CIBER Inc.
CBR
| $502K | 0.01% |
+237,841
| New | +$606K |
|
725
Huntington Bancshares
HBAN
$35.1B
| $495K | 0.01% |
51,890
-235,700
| -82% | -$2.17M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2016 Portfolio in Review
As of Q1 2016, Jacobs Levy Equity Management held 1,246 positions worth $4.72B, down 6.2% from $5.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management withdrew a net $247M in Q1 2016, closing 160 positions and reducing 328 holdings. Its most notable exit was Merck, an estimated $50.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Endo International plc worth $16.8M.
- Jacobs Levy Equity Management's largest Q1 2016 buy was Endo International plc: 596,209 shares worth $16.8M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2016, an estimated $32.6M increase.
- Jacobs Levy Equity Management's biggest Q1 2016 reduction was Walt Disney, cutting an estimated $49.8M.
- Jacobs Levy Equity Management fully exited Merck in Q1 2016, selling an estimated $50.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.72B portfolio in Q1 2016.
- Jacobs Levy Equity Management opened 455 new positions and closed 160 in Q1 2016.
- Jacobs Levy Equity Management's portfolio value fell 6.2% quarter-over-quarter to $4.72B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2016, filed 16 May 2016.